A German-US faculty/intern exchange program in biotechnology (original) (raw)
CHIMIA International Journal for Chemistry, 2007
The Institute of Biotechnology (formerly the Department of Biotechnology) at the Zurich University of Applied Sciences in Wädenswil has established itself internationally. Building-up expertise in complementary research fields as well as an orientation to German-speaking and/or small European countries have proved to be successful strategies to continually increase the amount of external funding for R&D projects (up to CHF 1.5 million expected in 2007). A bottom-up approach facilitated by lecturers' and students' individual initiatives has taken advantage of European and/or Swiss programmes (e.g. ERASMUS, IAESTE, Eureka, CTI and SVC). The international activities described have improved the quality of teaching and promoted the development of communication skills, enabling students to be better prepared for careers in international interdisciplinary teams. These activities have also assisted in the ongoing transformation of the study programmes to meet the requirements of the...
Global Clinics in Biotechnology: A Global Partnership between Industry and Academia
In the XXI st Century, access to high-speed and internet communication poses an interesting paradigm in engineering and science education, relying on the capability of academia to incorporate a global and interdisciplinary conscience into students' learning. Industry has, for a long time, lead globalization efforts due to its world-wide business nature. With this in mind, the Global Clinic in Biotechnology was established through collaboration among two academic partners, Harvey Mudd College and the University of Puerto Rico, Mayagüez Campus; and an industrial sponsor, Amgen Manufacturing, Limited. Student teams from the universities, of diverse cultural backgrounds and different disciplines of study, were assigned an industrial problem to be solved as a team. Each university branch was assigned faculty and industrial mentors. Faculty mentors provided counseling on the project's theoretical concepts at their campuses. Industrial mentors provided expertise on the project's goals and applied experimental setup. Thus, the experience of networking students from different cultural and disciplinary backgrounds was facilitated by the mentors. Progress on project, and consulting among teams, were communicated weekly using teleconferences or videoconferences. This paper will expose in detail how the Global Clinic in Biotechnology was established, how academia and industry collaborated to define an industrial project, and how the experience incorporated a global and interdisciplinary experience on the student's educational profiles.
Biotechnology education in Europe
Journal of Commercial Biotechnology, 2003
This study was not intended as a catalogue, but as a comparative overview of the range of opportunities for education in biotechnology open to citizens in the various member states of the EU -opportunities organised by governments and their agencies, by educational establishments, by a wide variety of organisations and institutions variously interested in informing/influencing public attitudes and, of course, by the media in its many forms. Switzerland was included because of its experience of a referendum on genetics and biotechnology as well as the USA, where it all started. A number of suggestions are made for improving public understanding of biotechnology and for establishing a code of best practice taking into account the cultural differences between countries. Perhaps the most important is that biotechnology education is a long-term issue requiring a long-term view; it should not be constrained by short-term funding.
The Fulbright Program in the Netherlands: An Example of Science Diplomacy
This chapter investigates the role and influence of the Fulbright Program, the principal mechanism for promoting educational interchange into and out of the United States, with focus on the Netherlands in the period between 1949 and 1980. It concentrates on the impact of the Program across all academic disciplines, but with special attention for the hard sciences. The Program was a flexible tool that could be adjusted to meet the needs of both the American and Dutch governments. Particular institutions – most notably the Dutch Foundation for Fundamental Research of Matter (FOM) – were able to make use of the Fulbright Program’s benefits to further their specific agendas in promoting scientific research in the Netherlands.
… , sponsored by the Commission of the …, 1995
Europe provides the home base for many of the world's leading chemical and pharmaceutical multinational companies. The success of this industry has been built on mastery of its core technology, synthetic organic chemistry. Recognising the significance of developments in biotechnology to their continued competitive success, companies have taken steps to acquire new biotechnology capabilities. In an effort to access American knowledge and capabilities, many European-based companies have set up or extended their US laboratories, and negotiated contracts with US academic laboratories and/or dedicated biotechnology companies. This project was designed to learn more about the organisation and management of biotechnology R&D by Europe's leading chemical/pharmaceutical multinational companies, and the relationship between their US and European research efforts. One of the aims of the study was to identify the needs of European chemical/pharmaceutical companies in relation to biotechnology in order to help the EU and its Member States to develop appropriate policies to support the continuing competitive success of this sector.
Europeans and Biotechnology in 2010 Winds of change?
2010
This is the seventh in a series of Eurobarometer surveys on life sciences and biotechnology conducted in 1991, 1993, 1996, 1999, 2002, 2005 and 2010. This latest survey, carried out in February 2010, was based on a representative sample of 30,800 respondents from the 27 Member States, plus Croatia, Iceland, Norway, Switzerland and Turkey.